alexa
Reach Us +44-1764-910199
Editor - Sanjun Shi | Third Military Medical University | 23230

Journal of Tumor Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Sanjun Shi

Sanjun Shi
Sanjun Shi
Department of Pharmacy
Third Military Medical University
Chongqing
China
Third Military Medical University

Biography

Dr. Sanjun Shi received his Ph.D. in Pharmacy from Sichuan University at Chengdu in 2013 under the supervision of Prof. Zhirong Zhang. He joined the Department of Pharmacy at Daping Hospital, Third Military Medical University as an Assistant Professor in July 2013. Dr. Shi’s research interests focus on the design, synthesis, characterization and evaluation of nanostructured biomaterials for drug delivery to enable treatments of tumor and the nanoparticle toxicity in vivo. He has published over 20 peer-reviewed articles, ~10 abstracts/presentations on these topics. His work was supported by the project of the National Natural Science Foundation of China. He has received the National Fellowship Programmes (China) and “1135” Excellent Talents Award in Daping hospital (2015).

Research Interest

Dr. Shi leads a research group involved in the nanoparticle delivery systems. His research focuses primarily on the design, synthesis, characterization and evaluation of nanostructured biomaterials for drug delivery to enable treatments of tumor and the nanoparticle toxicity in vivo.

Certificate

Certificate
Leave Your Message 24x7
Top